Mangoceuticals Inc
NASDAQ:MGRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.8), the stock would be worth $0.78 (86% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.4 | $0.42 |
0%
|
| 3-Year Average | 0.8 | $0.78 |
+86%
|
| 5-Year Average | 0.8 | $0.78 |
+86%
|
| Industry Average | 3.6 | $3.45 |
+728%
|
| Country Average | 2.5 | $2.4 |
+477%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| US |
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
6.6m USD | 0.4 | -0.3 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62.7B ZAR | 9.1 | 19.4 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | 5.6 | 25.3 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 1.4 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.5B BRL | 5.3 | 30.2 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
929.3B JPY | 1.1 | 21.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
911.6B JPY | 1.8 | 16.6 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 6.1 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.2B CNY | 2.5 | 16.9 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 2.5 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
574.6B JPY | 2 | 12.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.5 |
| Median | 2.5 |
| 70th Percentile | 4.8 |
| Max | 147 580.5 |
Other Multiples
Mangoceuticals Inc
Glance View
Mangoceuticals, Inc. engages in developing, marketing, and selling men’s wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The firm has developed and is in the process of preparing to commercially market a brand of erectile dysfunction (ED) product under the brand name Mango. The Company’s Mango ED product includes the ingredients, such as Tadalafil (10 milligrams (mg)), Oxytocin (100 International units (IU)) and L-Arginine (50mg), and Tadalafil (20mg), Oxytocin (100IU) and L-Arginine (50mg). The firm connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com for the provision of care via telehealth through its customer portal and provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including its Mango ED product.
